Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes

Table 2 CV of FPG and PPG obtained from SMBG among pregnant women with pT1D: MDI vs. CSII

	CV of SMBG (%)	MDI (n = 80)	CSII (n = 48)	P value
1st trimester	FPG	28.4	17.1	< 0.001
	PBG	24.2	20.4	0.22
	PLG	23.4	19.9	0.24
	PDG	14.1	13.8	0.85
2nd trimester	FPG	23.9	23.2	0.81
	PBG	24.1	23.1	0.75
	PLG	23.5	21.4	0.5
	PDG	14.8	13.7	0.56
3rd trimester	FPG	21.3	23.8	0.4
	PBG	17.0	14.1	0.01
	PLG	18.7	23.7	0.08
	PDG	12.1	14.6	0.16

Data are present as CV (%)
Coefficient of variation was calculated using the equation SD/\(\bar{x}\) of SMBG in different points (fasting or postprandial)
Levine F test was used to access the difference between CVs
Significance was found in the CSII group concerning FPG in the first and PBG in the third trimester measuring the CV of SMBG
Comparisons in boldface type indicate significant differences (p < 0.05)
FPG fasting plasma glucose, PBG postprandial breakfast glucose, PLG postprandial lunch glucose, PDG postprandial dinner glucose